A successful therapeutic trial for Amyloidosis

A successful therapeutic trial for Amyloidosis

A look back at a most successful therapeutic trial for Amyloidosis !
We are pleased to report that the trial is very promising and paves the way for a new therapy.

Read More
What is ATTRv amyloidosis?

What is ATTRv amyloidosis?

Amyloidosis is a group of rare diseases characterised by the abnormal deposition of amyloid proteins (proteins that misfold or twist to form “amyloid fibrils”) in various organs and tissues of…

Read More
The 4th European ATTR amyloidosis meeting

The 4th European ATTR amyloidosis meeting

The 4th European ATTR amyloidosis meeting for patients and physicians will be held on 2 and 3 November. To register, go online to the official event website: www.attramyloidosis2023.com It will…

Read More
What is the status of amyloidosis research?

What is the status of amyloidosis research?

Amyloidosis is a recent disease, first described in 1838 by Rudolph Virchow, a German pathologist, who identified abnormal deposits in the tissue of deceased patients. Since then, much research has…

Read More